Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Brainsway Ltd ADR 16 HARTUM STREET RAD TOWER 14TH FLOOR HAR HAHOTZVIM JERUSALEM L3 9777516 ISR

www.brainsway.com Employees: 120 P: 972-2582-4030

Sector:

Medical

Description:

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel.

Key Statistics

Overview:

Market Capitalization, $K 471,019
Enterprise Value, $K 401,399
Shares Outstanding, K 19,585
Float, K 15,864
% Float 81.00%
Short Interest, K 60
Short Float 0.31%
Days to Cover 1.00
Short Volume Ratio 0.40
% of Insider Shareholders 19.00%
% of Institutional Shareholders 30.11%

Financials:

Annual Sales, $ 41,020 K
Annual Net Income, $ 2,920 K
Last Quarter Sales, $ 13,510 K
Last Quarter Net Income, $ 1,570 K
EBIT, $ 2,840 K
EBITDA, $ 4,610 K

Growth:

1-Year Return 120.15%
3-Year Return 1,050.72%
5-Year Return 201.76%
5-Year Revenue Growth 77.58%
5-Year Earnings Growth 136.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.08 on 11/11/25
Next Earnings Date 03/10/26
Earnings Per Share ttm 0.30
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BWAY Ratios

Ratio
Price/Earnings ttm 82.37
Price/Earnings forward 45.20
Price/Earnings to Growth N/A
Return-on-Equity % 9.46%
Return-on-Assets % 5.96%
Profit Margin % 7.12%
Debt/Equity 0.00
Price/Sales 10.04
Price/Cash Flow 99.09
Price/Book 6.70
Book Value/Share 3.69
Interest Coverage 3.28
60-Month Beta 1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar